STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] CYBIN INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Cybin Inc. (CYBN): Schedule 13G/A Amendment No. 2 filed by Point72 entities reporting beneficial ownership of Cybin common shares. The filing lists 6,410,778 Common Shares beneficially owned with shared voting and dispositive power and 0 under sole power, representing 9.9% of the class as of the close of business on November 13, 2025.

The reported amount includes 2,109,338 Common Shares issuable upon exercise of warrants, which are subject to a 9.99% beneficial ownership blocker; some warrants are not presently exercisable due to this cap. As context, the aggregate percentage as of September 30, 2025 was based on 25,188,217 Common Shares outstanding as of September 16, 2025. The filing also notes that as of September 30, 2025, the reporting person may have been deemed to beneficially own 1,239,629 Common Shares, or 4.9%.

Ownership is held through Point72 Associates, LLC under an investment management agreement; Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen are reporting persons. They certify the securities were not acquired to change or influence control.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth on this cover page and in Item 4(b) reflects information as of the close of business on November 13, 2025 and includes 2,109,338 Common Shares (as defined in Item 2(a)) issuable upon exercise of warrants (the "Warrants"). As more fully described in Item 4, certain of the Warrants are subject to a 9.99% blocker (the "9.99% Blocker"), and the percentage set forth in row (11) gives effect to such 9.99% Blocker. However, as more fully described in Item 4, the Common Shares reported as being issuable upon exercise of Warrants in rows (6), (8) and (9) include the number of Common Shares that would be issuable upon full exercise of the Warrants and does not give effect to such 9.99% Blocker. Therefore, the actual number of Common Shares beneficially owned by such Reporting Person, after giving effect to such 9.99% Blocker, is less than the number of Shares reported in rows (6), (8) and (9) to be issuable upon exercise of the Warrants. As of September 30, 2025, the Reporting Person may have been deemed to beneficially own 1,239,629 Common Shares, representing 4.9% of the Common Shares outstanding as of such time.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 2,109,338 Common Shares issuable upon exercise of Warrants. As more fully described in Item 4, certain of the Warrants are subject to the 9.99% Blocker, and the percentage set forth in row (11) gives effect to such 9.99% Blocker. However, as more fully described in Item 4, the Common Shares reported as being issuable upon exercise of Warrants in rows (6), (8) and (9) include the number of Common Shares that would be issuable upon full exercise of the Warrants and does not give effect to such 9.99% Blocker. Therefore, the actual number of Common Shares beneficially owned by such Reporting Person, after giving effect to such 9.99% Blocker, is less than the number of Common Shares reported in rows (6), (8) and (9) to be issuable upon exercise of the Warrants. As of September 30, 2025, the Reporting Person may have been deemed to beneficially own 1,239,629 Common Shares, representing 4.9% of the Common Shares outstanding as of such time.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 2,109,338 Common Shares issuable upon exercise of Warrants. As more fully described in Item 4, certain of the Warrants are subject to the 9.99% Blocker, and the percentage set forth in row (11) gives effect to such 9.99% Blocker. However, as more fully described in Item 4, the Common Shares reported as being issuable upon exercise of Warrants in rows (6), (8) and (9) include the number of Common Shares that would be issuable upon full exercise of the Warrants and does not give effect to such 9.99% Blocker. Therefore, the actual number of Common Shares beneficially owned by such Reporting Person, after giving effect to such 9.99% Blocker, is less than the number of Common Shares reported in rows (6), (8) and (9) to be issuable upon exercise of the Warrants. As of September 30, 2025, the Reporting Person may have been deemed to beneficially own 1,239,629 Common Shares, representing 4.9% of the Common Shares outstanding as of such time.


SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/14/2025
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/14/2025
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/14/2025

FAQ

What stake in Cybin (CYBN) did Point72 report in this Schedule 13G/A?

The filing reports beneficial ownership of 6,410,778 Common Shares, representing 9.9% of the class as of November 13, 2025.

How many Cybin shares in the Point72 total are tied to warrants?

The reported total includes 2,109,338 Common Shares issuable upon exercise of warrants subject to a 9.99% blocker.

Who are the reporting persons for the Cybin (CYBN) stake?

Reporting persons are Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen.

What voting and dispositive powers were disclosed?

They reported shared voting power: 6,410,778 and shared dispositive power: 6,410,778; sole power: 0 for both.

What is the beneficial ownership cap on the warrants?

A 9.99% beneficial ownership blocker applies, limiting warrant exercise that would exceed 9.99% ownership.

What baseline share count did the percentage rely on earlier in the period?

Percentages as of September 30, 2025 referenced 25,188,217 Common Shares outstanding as of September 16, 2025.

Did the filers state an intent to influence control at Cybin (CYBN)?

They certified the securities were not acquired and are not held to change or influence control.
Cybin Inc

NYSE:CYBN

CYBN Rankings

CYBN Latest News

CYBN Latest SEC Filings

CYBN Stock Data

296.43M
18.77M
98.65%
38.53%
10.87%
Biotechnology
Healthcare
Link
Canada
Toronto